Top navigation
Navigation principale
Canicule,fortes chaleurs
Nutrition et activité physique
Maladies à signalement obligatoire
Follow our regional indicators by visiting our open data portal
Santé publique France is present throughout France with 16 regional units (12 in mainland France and 4 overseas), providing support to each of the regional health agencies (ARS).
View the heat wave and health bulletins related to the June 2026 heat wave:
Auvergne-Rhône-Alpes. Bulletin dated July 3, 2026.Nouvelle-Aquitaine. Bulletin dated July 3, 2026.Hauts-de-France. Bulletin dated July 3, 2026.Centre-Val de Loire. Bulletin dated July 3, 2026.Occitanie. Bulletin dated July 3, 2026.Normandy. Bulletin dated July 3, 2026.Brittany. Bulletin dated July 3, 2026.Pays de la Loire. Bulletin of July 3, 2026.Île-de-France. Bulletin of July 3, 2026.Provence-Alpes-Côte d’Azur. Bulletin of July 3, 2026.Corsica. Bulletin of July 3, 2026.Grand Est. Bulletin of July 3, 2026.
To stay up to date with our latest news, sign up for our free newsletters by filling out the form below
Below you will find our prevention and remote support websites, designed to assist the general public in a range of areas.
Reperprev.fr
Employers for Health
The Health Service
Learn more about our remote support services and dedicated websites
Here you will find direct links to our scientific journals and other publications, as well as to the Santé publique France documentation portal.
The latest issue of BEH
The latest issue of *La Santé en action*
Access all of Santé publique France’s documentary resources by consulting our document database (over 14,000 documents listed).
Here you will find the studies and surveys currently being conducted by Santé publique France or in collaboration with its partners.
Santé publique France is the national public health agency. Created in May 2016 by order and decree, it is a public administrative institution under the supervision of the Ministry of Health.
2024 Annual Report
2026 Work Program
2024–2028 Objectives and Performance Agreement
Strategy 2025–2030
Circulars and guidelines on the prevention of invasive meningococcal infections: Guideline No. DGS/SP/2018/163 of July 27, 2018, on the prevention of invasive meningococcal infections
2019 Vaccination Schedule
Meningococcal C Vaccination:
High Council for Public Health (HCSP). Opinion on meningococcal C vaccination. Paris: HSCP, December 9, 2016: 17 p.
High Council for Public Health: Opinion on vaccination with the serogroup C meningococcal conjugate vaccine – April 24 and June 26, 2009.
Vaccination against meningococcal ACWY:
High Authority for Health: Vaccination recommendation. Vaccination against invasive meningococcal infections of serogroup W with a tetravalent vaccine. Hyperendemic situations. January 2019.
High Council for Public Health: Opinion on the use of the tetravalent meningococcal conjugate vaccine A, C, Y, W135 Menveo® June 25, 2010.
High Council for Public Health: Opinion on the use of the tetravalent meningococcal conjugate vaccine A, C, Y, W135 NIMENRIX® and the respective roles of tetravalent conjugate and non-conjugate meningococcal vaccines, July 12, 2012.
Meningococcal B vaccination:
High Council for Public Health: Opinion on the use of the Bexsero® vaccine (Novartis Vaccines and Diagnostics) dated October 25, 2013
Vaccination of travelers against invasive meningococcal infections:
Health recommendations for travelers, 2022.